Document is current
Any future updates will be listed below
-
Authors
Lalwani, Geeta
Wykoff, Charles C.
Briggs, Jayla
Lin, Chin-Yu
Steffen, Verena
Haskova, Zdenka
-
Funding
Funding for this research was provided by:
Genentech, United States
- License Information
-
More Information
Article History
Received: 2 December 2024
Accepted: 29 July 2025
First Online: 6 October 2025
Declarations
:
: The study was approved by the University of Oklahoma Health Sciences Center Institutional Review Board (#INV-001) and participants provided written informed consent prior to capture of photographs.
: Not applicable.
: GW: Advisor for Ocugen; honoraria from Genentech, Inc., Novartis, Regeneron. CCW: Consultant for Bayer; grant recipient from Genentech, Inc./Roche, Novartis, Regeneron. JB, VS, ZH: Employee of Genentech, Inc. and may be stakeholders in Roche. C-YL: Former employee of Genentech, Inc.
